The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat

Neurogastroenterology and Motility

Volumn 22, Issue 6, 2010, Pages

  Abalo, R ^a   Cabezos, P A ^a   Vera, G ^a   Fernandez Pujol R ^a   Martin M I ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Cannabinoid receptors; Gastrointestinal motility; Radiology; Rat

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID 2 RECEPTOR; CANNABINOID 2 RECEPTOR ANTAGONIST; CONTRAST MEDIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; GASTROINTESTINAL MOTILITY; INTESTINE RADIOGRAPHY; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; STOMACH EMPTYING;

ANIMALS; BENZOXAZINES; BORNANES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GASTRIC EMPTYING; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; INDOLES; MALE; MORPHOLINES; NAPHTHALENES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID;

EID: 77951962140     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2009.01466.x     Document Type: Article

References (45)

1. Duncan M, Davison JS, Sharkey KA. Review article: Endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther 2005 22 : 667 683. (Pubitemid 41475329)
2. Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut 2008 57 : 1140 1155.
3. Izzo AA, Coutts AA. Cannabinoids and the digestive tract. Handb Exp Pharmacol 2005 168 : 573 598.
4. Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006 58 : 389 462. (Pubitemid 44394908)
5. Pertwee RG. Cannabinoids and the gastrointestinal tract. Gut 2001 48 : 859 867.
6. Howlett AC, Barth F, Bonner TI et al. International Union of Pharmacology. XXVII Classification of cannabinoid receptors. Pharmacol Rev 2002 54 : 161 202. (Pubitemid 34575709)
7. Klein TW. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 2005 5 : 400 411.
8. Cota D. CB1 receptors: Emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health. Diabetes Metab Res Rev 2007 23 : 507 517. (Pubitemid 350018024)
9. Mallat A, Lotersztajn S. Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver. Am J Physiol Gastrointest Liver Physiol 2008 294 : G9 12.
10. Van Sickle M, Duncan M, Kingsley PJ et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005 310 : 329 332.
11. Wright KL, Duncan M, Sharkey KA. Cannabinoid CB2 receptors in the gastrointestinal tract: A regulatory system in states of inflammation. Br J Pharmacol 2008 153 : 263 270.
12. Duncan M, Mouihate A, Mackie K et al. Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats. Am J Physiol Gastrointest Liver Physiol 2008 295 : G78 87.
13. Storr M, Gaffal E, Saur D, Schusdziarra V, Allescher HD. Effect of cannabinoids on neural transmission in rat gastric fundus. Can J Physiol Pharmacol 2002 80 : 67 76. (Pubitemid 34194288)
14. Griffin G, Fernando SR, Ross RA et al. Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. Eur J Pharmacol 1997 339 : 53 61. (Pubitemid 28015431)
15. Izzo AA, Mascolo N, Pinto L, Capasso R, Capasso F. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats. Eur J Pharmacol 1999 384 : 37 42.
16. Cabezos PA, Vera G, Castillo M, Fernández-Pujol R, Martin MI, Abalo R. Radiological study of gastrointestinal motor activity after acute cisplatin in the rat. Temporal relationship with pica. Auton Neurosci 2008 141 : 54 65.
17. Abalo R, Cabezos PA, López-Miranda V et al. Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat. Neurogastroenterol Motil 2009 21 : 1002 e80.
18. Izzo AA, Mascolo N, Capasso R, Germanò MP, De Pasquale R, Capasso F. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat. Naunyn Schmiedebergs Arch Pharmacol 1999 360 : 221 223. (Pubitemid 29420029)
19. Mathison R, Ho W, Pittman QJ, Davison JS, Sharkey KA. Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats. Br J Pharmacol 2004 142 : 1247 1254. (Pubitemid 39178878)
20. Compton DR, Rice KC, De Costa BR et al. Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 1993 265 : 218 226.
21. Pertwee RG, Stevenson LA, Elrick DB, Mechoulam R, Corbett AD. Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br J Pharmacol 1992 105 : 980 984.
22. Pascual D, Goicoechea C, Suardíaz M, Martín MI. A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats. Pain 2005 118 : 23 34. (Pubitemid 41566582)
23. Vera G, Chiarlone A, Cabezos PA, Pascual D, Martín MI, Abalo R. WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat. Life Sci 2007 81 : 468 479. (Pubitemid 47175976)
24. Rahn EJ, Makriyannis A, Hohmann AG. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats. Br J Pharmacol 2007 152 : 765 777. (Pubitemid 350041538)
25. Onaivi ES, Ishiguro H, Gong JP et al. Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. Ann NY Acad Sci 2008 1139 : 434 449. (Pubitemid 351865466)
26. Valenzano KJ, Tafesse L, Lee G et al. Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy. Neuropharmacology 2005 48 : 658 672. (Pubitemid 40462406)
27. Aceto MD, Scates SM, Martin BB. Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2. Eur J Pharmacol 2001 416 : 75 81.
28. Page ME, Oropeza VC, Sparks SE, Qian Y, Menko AS, Van Bockstaele EJ. Repeated cannabinoid administration increases indices of noradrenergic activity in rats. Pharmacol Biochem Behav 2007 86 : 162 168. (Pubitemid 46274981)
29. Fox A, Kesingland A, Gentry C et al. The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain 2001 92 : 91 100. (Pubitemid 32367940)
30. Hornby PJ, Prouty SM. Involvement of cannabinoid receptors in gut motility and visceral perception. Br J Pharmacol 2004 141 : 1335 1345.
31. Massa F, Storr M, Lutz B. The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract. J Mol Med 2005 83 : 944 954. (Pubitemid 41745753)
32. Pertwee RG. Inverse agonism and neutral antagonism at cananbinoid CB1 receptor. Life Sci 2005 76 : 1307 1324.
33. Colombo G, Agabio R, Lobina C, Reali R, Gessa GL. Cannabinoid modulation of intestinal propulsion in mice. Eur J Pharmacol 1998 344 : 67 9. (Pubitemid 28143949)
34. Izzo AA, Pinto L, Borrelli F, Capasso R, Mascolo N, Capasso F. Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil. Br J Pharmacol 2000 129 : 1627 1632. (Pubitemid 30219004)
35. Pertwee RG, Fernando SR, Nash JE, Coutts AA. Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. Br J Pharmacol 1996 118 : 2199 2205. (Pubitemid 26292596)
36. Izzo AA, Mascolo N, Borrelli F, Capasso F. Excitatory transmission to the circular muscle of the guinea-pig ileum: Evidence for the involvement of cannabinoid CB1 receptors. Br J Pharmacol 1998 124 : 1363 1368. (Pubitemid 28360557)
37. Calignano A, La Rana G, Makriyannis A, Lin SY, Beltramo M, Piomelli D. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. Eur J Pharmacol 1997 340 : R7 8. (Pubitemid 28022658)
38. Pinto L, Izzo AA, Cascio MG et al. Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology 2002 123 : 227 234. (Pubitemid 34747543)
39. Pertwee RG. Ligands that target cannabinoid receptors in the brain: From THC to anandamide and beyond. Addict Biol 2008 13 : 147 159.
40. Landi M, Croci T, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Manara L. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors. Eur J Pharmacol 2002 450 : 77 83.
41. Di Marzo V, Capasso R, Matias I et al. The role of endocannabinoids in the regulation of gastric emptying: Alterations in mice fed a high-fat diet. Br J Pharmacol 2008 153 : 1272 1280. (Pubitemid 351415503)
42. Mule F, Amato A, Baldassano S, Serio R. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations. Pharmacol Res 2007 56 : 185 192. (Pubitemid 47321201)
43. Kimball ES, Schneider CR, Wallace NH, Hornby PJ. Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium. Am J Physiol Gastrointest Liver Physiol 2006 291 : G364 71.
44. Sanson M, Bueno L, Fioramonti J. Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats. Neurogastroenterol Motil 2006 18 : 949 956. (Pubitemid 44358865)
45. Wright K, Rooney N, Feeney M et al. Differential expression of cannabinoid receptors in the human colon: Cannabinoids promote epithelial wound healing. Gastroenterology 2005 129 : 437 453. (Pubitemid 41096632)